Onchocerciasis-associated epilepsy and biomarkers
- PMID: 38722830
- PMCID: PMC11081238
- DOI: 10.1371/journal.pntd.0011808
Onchocerciasis-associated epilepsy and biomarkers
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- World Health Organisation. Report of the sixth meeting of the WHO Onchocerciasis Technical Advisory Subgroup: virtual meeting, 19–21 December 2022. 2022. Available at https://www.who.int/publications/i/item/9789240071469 Accessed 8 November 2023
-
- Bhwana D, Amaral LJ, Mhina A, Matine P, Francis F, Siewe Fodjo JN, et al.. Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study. PLoS Negl Trop Dis. 2023;17(6):e0011178. Epub 20230628. doi: 10.1371/journal.pntd.0011178 . - DOI - PMC - PubMed
-
- Gumisiriza N, Kaiser C, Asaba G, Onen H, Mubiru F, Kisembo D, et al.. Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies. Lancet Infect Dis. 2020;20(11):1315–23. Epub 2020/07/01. doi: 10.1016/S1473-3099(20)30122-5 . - DOI - PubMed
-
- Gumisiriza N, Mubiru F, Siewe Fodjo JN, Mbonye Kayitale M, Hotterbeekx A, Idro R, et al.. Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures. Infect Dis Poverty. 2020;9(1):12. Epub 2020/03/03. doi: 10.1186/s40249-020-0628-3 ; PubMed Central PMCID: PMC7050130. - DOI - PMC - PubMed
-
- Jada SR, Amaral LJ, Lakwo T, Carter JY, Rovarini J, Bol YY, et al.. Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study. Lancet Glob Health. 2023;11(8):e1260–e8. doi: 10.1016/S2214-109X(23)00248-6 . - DOI - PubMed